Robert Shih-Liang Chao

Title: Innovations and Contributions of Robert Shih-Liang Chao

Introduction

Robert Shih-Liang Chao, based in Portage, MI, is a prominent inventor recognized for his significant contributions to the pharmaceutical field. With a total of three patents to his name, Chao's work primarily focuses on innovative compositions that enhance the treatment of bacterial infections.

Latest Patents

Chao's latest patents showcase his commitment to developing effective medicinal formulations. One of his notable inventions is the "Intravaginal Clindamycin Ovule Composition." This invention pertains to a highly storage-stable composition designed for vaginal administration of clindamycin, an antibiotic that is beneficial in treating bacterial vaginosis. The composition takes the form of a vaginal suppository, wherein clindamycin is efficiently dispersed in a Hard Fat NF suppository base. This formulation not only ensures long-term storage stability of the active ingredient but also offers therapeutic efficacy comparable to existing clindamycin vaginal creams.

Another groundbreaking patent by Chao involves the "Physically Stable Solid Form of a Fluoroquinolone." This patent discloses novel crystal forms of the fluoroquinolone compound, characterized by a methanol solvate form and three distinct anhydrous polymorphic forms. Among these, Form III has been highlighted for its remarkable stability and reduced hygroscopicity, making it a promising candidate for further development in antibiotic treatments.

Career Highlights

Robert Chao is affiliated with the Pharmacia & Upjohn Company, a leading pharmaceutical organization where he has leveraged his expertise to drive innovation in drug formulation. His work at the company underscores his dedication to enhancing therapy effectiveness through innovative scientific approaches.

Collaborations

Chao has collaborated with distinguished colleagues, including Michael J. Dunn and Michael S. Bergren. These partnerships reflect a collaborative spirit in the pursuit of groundbreaking solutions in the pharmaceutical industry.

Conclusion

In summary, Robert Shih-Liang Chao stands out as a significant inventor whose contributions to the field of pharmaceuticals continue to impact the treatment of bacterial infections. His innovative work in developing stable formulations exemplifies the importance of research and collaboration in advancing healthcare solutions.